People who have had mild illness develop antibody-producing cells that can last lifetime
People who have had a mild case of COVID-19 are left with long-term antibody protection against future disease, according to a study from researchers at Washington University School of Medicine. (Photo: Getty Images)
May 24, 2021 SHARE
Months after recovering from mild cases of COVID-19, people still have immune cells in their body pumping out antibodies against the virus that causes COVID-19, according to a study from researchers at Washington University School of Medicine in St. Louis. Such cells could persist for a lifetime, churning out antibodies all the while.
The U.S. new cases 7-day rolling average are 23.7 % LOWER than the 7-day rolling average one week ago and U.S. deaths due to coronavirus are now 7.7 %
LOWER than the rolling average one week ago. Today s posts include:
U.S. Coronavirus New Cases are 14,144
U.S. Coronavirus deaths are at 189
U.S. Coronavirus immunizations have been administered to 85.4 doses per 100 people.
The 7-day rolling average rate of growth of the pandemic shows new cases were little changed and deaths improved Not convinced COVID-19 developed naturally, need more open investigations: Dr Anthony Fauci
New information on Wuhan researchers illness furthers the debate on pandemic origins
Advertisement
HOME > LIFE & CULTURE >Immune system has long-term defenses after mild COVID-19; children may be key carriers of virus variants
Immune system has long-term defenses after mild COVID-19; children may be key carriers of virus variants
Reuters | May 24, 2021 04:42 PM EDT
A woman holds a small bottle labelled with a Coronavirus COVID-19 Vaccine sticker and a medical syringe in this illustration (Photo : REUTERS/Dado Ruvic/File Photo)
The following is a roundup of some of the latest scientific studies on the novel coronavirus and efforts to find treatments and vaccines for COVID-19, the illness caused by the virus.
Immune system may never forget mild COVID-19
Immune system has long-term defenses after mild COVID-19; children may be key carriers of virus variants kwsn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kwsn.com Daily Mail and Mail on Sunday newspapers.
We stared at the data for a long time partly in disbelief. Douglas Mann, MD, of Washington University School of Medicine in St. Louis, on how sacubitril/valsartan (Entresto) didn t appear to help patients with advanced heart failure when compared with an angiotensin receptor blocker alone. I think asking people to just sort of go with this guidance at the drop of a hat was really a bombshell, and certainly didn t give public health authorities or institutional authorities time to prepare. Jeanne Marrazzo, MD, of the University of Alabama at Birmingham, discussing the mistakes in how the CDC announced their new mask guidance.